Identifying the key functions of MeCP2 via genetic manipulation in mice
dc.contributor.advisor
Bird, Adrian
en
dc.contributor.advisor
Cook, Atlanta
en
dc.contributor.author
Tillotson, Anne Rebekah
en
dc.contributor.sponsor
Biotechnology and Biological Sciences Research Council (BBSRC)
en
dc.date.accessioned
2018-03-22T11:25:48Z
dc.date.available
2018-03-22T11:25:48Z
dc.date.issued
2017-07-07
dc.description.abstract
MeCP2 was identified by its ability to bind DNA in a methylation-specific manner.
Yet, how it interprets the DNA methylome remains unclear. Several mechanisms
have been proposed, including a role in transcriptional repression. MeCP2 is highly
abundant in the brain, and loss-of-function mutations result in a neurological disorder
called Rett syndrome (RTT). Strikingly, RTT-causing missense mutations are almost
all located in either the methyl-CpG-binding domain (MBD) or a region that has
been shown to bind the NCoR/SMRT co-repressor complex (NID). This suggests
that the MBD and the NID are the key functional domains in MeCP2, and that the
role of MeCP2 is to form a ‘bridge’ between chromatin and the co-repressor complex
to regulate gene expression. To test this ‘bridge’ hypothesis, I have made an allelic
series of knock-in mice with truncated forms of MeCP2 to determine whether the
other regions are dispensable for protein function. The three other regions of MeCP2
(the N-terminus before the MBD, the Intervening region between the MBD and the
NID, and the C-terminus after the NID) were deleted in a step-wise manner to
produce progressively smaller truncated proteins. Knock-in mice which lack just the
N-terminus or both the N- and C-termini are phenotypically normal. Therefore, these
regions, which together make up 46% of the protein sequence, are dispensable for
MeCP2 function in vivo. Additional deletion of the Intervening region, retaining only
34% of the original sequence, results in mild RTT-like symptoms in the knock in
mice. This is likely to be caused by this protein’s decreased stability and reduced
ability to bind the NCoR/SMRT complex in the brain. The most severely truncated
protein is nevertheless able to reverse the Mecp2-null phenotype when reactivated
after the onset of symptoms. Together, these findings strongly support the ‘bridge’
hypothesis.
en
dc.identifier.uri
http://hdl.handle.net/1842/28917
dc.language.iso
en
dc.publisher
The University of Edinburgh
en
dc.subject
MeCP2
en
dc.subject
epigenetic
en
dc.subject
mouse model
en
dc.subject
gene expression
en
dc.title
Identifying the key functions of MeCP2 via genetic manipulation in mice
en
dc.type
Thesis or Dissertation
en
dc.type.qualificationlevel
Doctoral
en
dc.type.qualificationname
PhD Doctor of Philosophy
en
Files
Original bundle
1 - 1 of 1
- Name:
- Tillotson2017.pdf
- Size:
- 12.81 MB
- Format:
- Adobe Portable Document Format
This item appears in the following Collection(s)

